Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Malignant glioma therapy

Husain SR, Puri RK. Interleukin-13 receptor-directed C3do-toxin for malignant glioma therapy from bench to bedside. J Neurooncol 2003 65 37—48. [Pg.366]

Chen TC,SuS, FryD,Liebes L (2003) Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma. Cancer 97 2363-2373... [Pg.114]

Results with Surgery and Radiation Therapy Trials of Chemotherapeutic Agents Recursive Partitioning Analysis Specific Therapy Considerations in non-GBM Malignant Gliomas Radiation Therapy Strategies Novel Chemotherapeutic Agents Future Directions References... [Pg.129]

Curran WJ, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993 85 704-710. [Pg.142]

Werner-Wasik M, Scott CB, Nelson DF, et al. Final report of a Phase I/II trial of hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas Radiation Therapy Oncology Group study 83-02. Cancer 1996 77 1535-1543. [Pg.143]

Staba MJ, Mauceri HJ, Kufe DW, et al. Adenoviral TNF-a gene therapy and radiation damage tumor vasculature in a human malignant glioma xenografts. Gene Ther 1998 5 293-300. [Pg.377]

Nitta, T, K. Sato, H. Yagita, K. Okumura, and S. Ishii, Preliminary trial of specific targeting therapy against malignant glioma. Lancet, 1990. 335(8686) 368-71. [Pg.288]

Norden AD, Drappatz J, Wen PY (2008) Novel anti-angiogenic therapies for malignant gliomas. Lancet Neurol 7 1152-1160... [Pg.820]

Rege, T.A., Fears, C.Y. and Gladson, C.L. (2005) Endogenous inhibitors of angiogenesis in malignant gliomas nature s antiangiogenic therapy. Neuro-oncol. 7, 106—121. [Pg.129]

Papavero L, Loew F, Jaksche H. Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Clinical aspects and critical considerations. Acta Neurochir (Wien) 1987 85(3-4) 128-37. [Pg.78]

Leff RS, Thompson JM, Daly MB, Johnson DB, Harden EA, Mercier RJ, Messerschmidt GL. Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma. Cancer 1988 62(l) 32-5. [Pg.3466]

Kondo Y, Komata T, Kondo S. 2001. Combination therapy of 2-5A antisense agai nst telomerase RNA and cisplatin for malignant gliomas. Int. J. Oncol. 18 1287-92... [Pg.377]

Brem H, Ewend MG, Piantadosi S, et al. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas phase I trial. J Neurooncol 1995 26 111-123. [Pg.21]

See other pages where Malignant glioma therapy is mentioned: [Pg.1140]    [Pg.343]    [Pg.91]    [Pg.1140]    [Pg.343]    [Pg.91]    [Pg.154]    [Pg.76]    [Pg.129]    [Pg.131]    [Pg.132]    [Pg.133]    [Pg.133]    [Pg.134]    [Pg.135]    [Pg.135]    [Pg.137]    [Pg.138]    [Pg.139]    [Pg.139]    [Pg.140]    [Pg.141]    [Pg.143]    [Pg.421]    [Pg.421]    [Pg.239]    [Pg.280]    [Pg.139]    [Pg.518]    [Pg.529]    [Pg.810]    [Pg.811]    [Pg.1455]    [Pg.77]    [Pg.698]    [Pg.275]   
See also in sourсe #XX -- [ Pg.1140 ]



SEARCH



Gliomas

Malignancy

Malignant

Malignant gliomas

Malignant gliomas radiation therapy

© 2024 chempedia.info